|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 9/12 |
| (11) | Number of the document | 1519746 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03771818.6 |
| Date of filing the European patent application | 2003-07-24 | |
| (97) | Date of publication of the European application | 2005-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2009-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/023235 |
| Date | 2003-07-24 |
| (87) | Number | WO 2004/011028 |
| Date | 2004-02-05 |
| (30) | Number | Date | Country code |
| 202957 | 2002-07-25 | US | |
| 292338 | 2002-11-12 | US |
| (72) |
Adair, Charles David, US
|
| (73) |
Adair, Charles David,
22 Mountain Orchard Path, Signal Mountain, TN 37377,
US
|
| (54) | USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS |
| USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS |